Hypercalcemia in granulomatous diseases as tuberculosis (TB) is uncommon. We describe a case of a 21year-old male whose serum calcium level was 14 mg/dL at the time of admission. Chest imaging revealed a cavity at the top of both lungs as well as the closure of the right laberal angle. The sputum smears and culture were evaluated regarding Mycobacterium tuberculosis and the findings of the smear and culture were reported as positive. As the values of creatinine were increased, renal failure had to be investigated. Both pathological mechanisms appear to affect the renal function. The anti-TB treatment included isoniazid 5 mg/kg, rifampicin 10 mg/kg and pyrazinamide 20 mg/kg once daily for two months and then the therapy continued with isoniazid and pyrazinamide up to eight months. The patient also received hydration, loop diuretics, and prednisolone (20 mg per day). One week after the introduction of the corticosteroid therapy, the patient's serum creatinine and calcium (Ca) levels decreased (4 mg/dL to 2 mg/dL, and 14 mg/dL to 10 mg/dL, respectively). Hypercalcemia, renal failure, interstitial nephritis, and proteinuria are rare in pulmonary tuberculosis but should be considered as severe complications. Therefore, hypercalcemia should be first controlled by hydration or some steroids along with the treatment of TB, and introduction of loop diuretics and nutritional constraints.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.